Research programme: cancer vaccines - Onyvax
Alternative Names: Onyvax-L; Onyvax-M; Onyvax-RLatest Information Update: 01 Jun 2010
At a glance
- Originator Onyvax
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Lung cancer; Multiple myeloma; Renal cancer
Most Recent Events
- 05 Mar 2004 This compound is still in active development
- 13 Feb 2003 Preclinical trials in Renal cancer in United Kingdom (unspecified route)